Douglass M. Diak

Dr. Douglass M. Diak


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2022 in Viruses
Verified
Journal Article
Open access
PDF file
SMSatish Mehta
Satish Mehta
Moriah SzparaMoriah Szpara
Moriah Szpara
BRBridgette V. Rooney
Bridgette V. Rooney
DDDouglass M. Diak
Douglass M. Diak
MSMackenzie M. Shipley
Mackenzie M. Shipley
BCBrian Crucian
Brian Crucian
Human alpha herpesviruses herpes simplex virus (HSV-1) and varicella zoster virus (VZV) establish latency in various cranial nerve ganglia and often reactivate in response to stress-associated immune system dysregulation. Reactivation of Epstein Barr virus (EBV), VZV, HSV-1, and cytomegalovirus (CMV) is typically asymptomatic during spaceflight, though live/infectious virus has been recovered and the shedding rate increases with mission duration. The risk of clinical disease, therefore, may increase for astronauts assigned to extended missions (>180 days). Here, we report, for the first time, a case of HSV-1 skin rash (dermatitis) occurring during long-duration spaceflight. The astronaut reported persistent dermatitis during flight, which was treated onboard with oral antihistamines and topical/oral steroids. No HSV-1 DNA was detected in 6-month pre-mission saliva samples, but on flight day 82, a saliva and rash swab both yielded 4.8 copies/ng DNA and 5.3 × 104 copies/ng DNA, respectively. Post-mission saliva samples continued to have a high infectious HSV-1 load (1.67 × 107 copies/ng DNA). HSV-1 from both rash and saliva samples had 99.9% genotype homology. Additional physiological monitoring, including stress biomarkers (cortisol, dehydroepiandrosterone (DHEA), and salivary amylase), immune markers (adaptive regulatory and inflammatory plasma cytokines), and biochemical profile markers, including vitamin/mineral status and bone metabolism, are also presented for this case. These data highlight an atypical presentation of HSV-1 during spaceflight and underscore the importance of viral screening during clinical evaluations of in-flight dermatitis to determine viral etiology and guide treatment.

13 May 2024 in Cancer Research Communications
Verified
Journal Article
Open access
PDF file
Forrest BakerForrest Baker
Forrest Baker
KSKyle A. Smith
Kyle A. Smith
PMPreetesh L. Mylabathula
Preetesh L. Mylabathula
TZTiffany M. Zúñiga
Tiffany M. Zúñiga
DDDouglass M. Diak
Douglass M. Diak
EKEmmanuel Katsanis
Emmanuel Katsanis
Exercise mobilizes cytotoxic lymphocytes to blood which may allow superior cell products to be harvested and manufactured for cancer therapy. Gamma-Delta (γδ) T-cells have shown promise for treating solid tumors, but there is a need to increase their potency against hematologic malignancies. Here, we show that human γδ T-cells mobilized to blood in response to just 20 minutes of graded exercise have surface phenotypes and transcriptomic profiles associated with cytotoxicity, adhesion, migration, and cytokine signaling. Following 14 days ex vivo expansion with zoledronic acid and IL2, exercise mobilized γδ T-cells had surface phenotypes and transcriptomic profiles associated with enhanced effector functions and demonstrated superior cytotoxic activity against multiple hematologic tumors in vitro and in vivo in leukemia-bearing xenogeneic mice. Infusing humans with the β1+β2-agonist isoproterenol and administering β1 or β1+β2 antagonists prior to exercise revealed these effects to be β2-adrenergic receptor (AR) dependent. Antibody blocking of DNAM-1 on expanded γδ T-cells, as well as the DNAM-1 ligands PVR and Nectin-2 on leukemic targets, abolished the enhanced antileukemic effects of exercise. These findings provide a mechanistic link between exercise, β2-AR activation, and the manufacture of superior γδ T-cell products for adoptive cell therapy against hematologic malignancies. Significance: Exercise mobilizes effector γδ T-cells to blood via β2-adrenergic signaling which allows for generation of a potent expanded γδ T-cell product that is highly cytotoxic against hematologic malignancies.

Verified
Journal Article
Open access
PDF file
SMSatish Mehta
Satish Mehta
DDDouglass M. Diak
Douglass M. Diak
SBSara Bustos-Lopez
Sara Bustos-Lopez
MNMayra Nelman-Gonzalez
Mayra Nelman-Gonzalez
XCXi Chen
Xi Chen
BCBrian Crucian
Brian Crucian
Human exploration of the solar system will expose crew members to galactic cosmic radiation (GCR), with a potential for adverse health effects. GCR particles (protons and ions) move at nearly the speed of light and easily penetrate space station walls, as well as the human body. Previously, we have shown reactivation of latent herpesviruses, including herpes simplex virus, Varicella zoster virus, Epstein–Barr virus, and cytomegalovirus (CMV), during stays at the International Space Station. Given the prevalence of latent CMV and the known propensity of space radiation to cause alterations in many cellular processes, we undertook this study to understand the role of GCR in reactivating latent CMV. Latently infected Kasumi cells with CMV were irradiated with 137Cs gamma rays, 150 MeV protons, 600 MeV/n carbon ions, 600 MeV/n iron ions, proton ions, and simulated GCR. The CMV copy number increased significantly in the cells exposed to radiation as compared with the non-irradiated controls. Viral genome sequencing did not reveal significant nucleotide differences among the compared groups. However, transcriptome analysis showed the upregulation of transcription of the UL49 ORF, implicating it in the switch from latent to lytic replication. These findings support our hypothesis that GCR may be a strong contributor to the reactivation of CMV infection seen in ISS crew members.

12 December 2024 in Viruses
Verified
Journal Article
Open access
PDF file
DDDouglass M. Diak
Douglass M. Diak
BCBrian Crucian
Brian Crucian
MNMayra Nelman-Gonzalez
Mayra Nelman-Gonzalez
SMSatish Mehta
Satish Mehta
Many biological markers of normal and disease states can be detected in saliva. The benefits of saliva collection for research include being non-invasive, ease of frequent sample collection, saving time, and being cost-effective. A small volume (≈1 mL) of saliva is enough for these analyses that can be collected in just a few minutes. For “dry” saliva paper matrices, additional drying times (about 30 min) may be needed, but this can be performed at room temperature without the need for freezers and specialized equipment. Together, these make saliva an ideal choice of body fluid for many clinical studies from diagnosis to monitoring measurable biological substances in hospital settings, remote, and other general locations including disaster areas. For these reasons, we have been using saliva (dry as well as wet) from astronauts participating in short- and long-duration space missions for over two decades to conduct viral, stress, and immunological studies. We have also extended the use of saliva to space analogs including bed rest, Antarctica, and closed-chamber studies. Saliva is a biomarker-rich and easily accessible body fluid that could enable larger and faster public health screenings, earlier disease detection, and improved patient outcomes. This review summarizes our lessons learned from utilizing saliva in spaceflight research and highlights the advantages and disadvantages of saliva in clinical diagnostics.

29 August 2025 in Cancers
Verified
Journal Article
Open access
PDF file
HBHelena Batatinha
Helena Batatinha
NPNicole A. Peña
Nicole A. Peña
Giovannah Alexis HoskinGiovannah Alexis Hoskin
Giovannah Alexis Hoskin
TKTimothy M. Kistner
Timothy M. Kistner
DDDouglass M. Diak
Douglass M. Diak
EKEmmanuel Katsanis
Emmanuel Katsanis
Background: Donor lymphocyte infusion (DLI) is employed to enhance the graft-versus-leukemia (GvL) effect and improve remission rates following allogeneic hematopoietic cell transplantation (alloHCT). However, graft-versus-host disease (GvHD) remains a significant complication of both alloHCT and DLI. Regular exercise has been shown to reduce cancer risk, enhance treatment responses, and mitigate therapy-related toxicities. This study investigated the effects of voluntary wheel running on GvL and GvHD following DLI in a xenogeneic mouse model. Methods: Immunodeficient NSG-IL15 mice were challenged with a luciferase-expressing chronic myelogenous leukemia cell line (K562), and then they received DLI with peripheral blood mononuclear cells (PBMCs) from healthy volunteers (GvL model). Non-tumor bearing mice received DLI to model GvHD. Half of the mice in each group were then given free access to a running wheel. Tumor growth (bioluminescence), GvHD, and body weight were monitored biweekly for ~40 days. Results: In the GvHD model, exercise extended overall survival by 60% and reduced GvHD severity. In the GvL model, exercise significantly lowered tumor burden and extended tumor-free survival in both DLI and vehicle control groups by 44.5% and 37.5%, respectively, suggesting both immune-dependent and immune-independent mechanisms. RNA sequencing of bone marrow from saline-injected mice revealed that genes associated with mitochondrial function, protein synthesis, and metabolic processes were downregulated in tumors from exercised mice. Conclusions: In summary, voluntary wheel running improved DLI outcomes by enhancing GvL and reducing GvHD. These benefits may be mediated, in part, through exercise-induced metabolic reprogramming of leukemia cells.

13 May 2024
Verified
Other
Open access
Forrest BakerForrest Baker
Forrest Baker
KSKyle A. Smith
Kyle A. Smith
PMPreetesh L. Mylabathula
Preetesh L. Mylabathula
TZTiffany M. Zúñiga
Tiffany M. Zúñiga
DDDouglass M. Diak
Douglass M. Diak
EKEmmanuel Katsanis
Emmanuel Katsanis
ISO infusion enhances the antileukemic activity of ex vivo expanded Vγ9Vδ2+ T-cells in vitro and in vivo. A, Schematic of the experimental design for in vitro and in vivo experiments. B, The total number (1 × 106) of Vγ9Vδ2+ cells isolated before (REST) and during the final 5 minutes of ISO infusion at day 0, and the total number of Vγ9Vδ2+ T-cells generated in the expanded cell products after stimulation with ZOL+IL2 for 14 days. The number of Vγ9Vδ2+ cells generated at day 14 relative to the number of γδ cells in the PBMC fractions at day 0. The cellular composition of the expanded Vγ9Vδ2+ T-cell products at day 14. The proportions of naïve (N), CM, EM, and CD45RA+ EMRA cells among Vγ9Vδ2+ T-cells after 14 days of expansion (n = 7). C, The in vitro anti-tumor activity of ex vivo expanded Vγ9Vδ2+ T-cells against K562, Daudi, and U266 cells via flow cytometry–based assays. Significance indicated by ** (P < 0.01) and *** (P < 0.001). D, To determine the in vivo GvL effect of ISO expanded Vγ9Vδ2+, NSG-IL15 mice were injected with REST or ISO expanded Vγ9Vδ2+ (10 × 106) and challenged with 1 × 106 luciferase tagged human chronic myeloid leukemia cells (K562-luc). A subset of mice in each group were also provided weekly injections of ZOL (REST+ZOL; ISO+ZOL; VEHICLE +ZOL). The BLI (photons/second) scores, TFS, change in BW, and probability of survival after injection of expanded Vγ9Vδ2+ T-cells with or without ZOL sensitization (n = 7–8/group). BLI significant difference from EX+ZOL and EX conditions indicated by * and #, respectively (all conditions were significantly different from vehicle controls). TFS, BW, and OS significant difference from vehicle controls were indicated by * (TFS; EX, EX+ZOL, and REST+ZOL significance indicated by a single marker). E, Representative bioluminescence images of leukemia-bearing mice that received (from left to right) vehicle, vehicle + ZOL, REST expanded Vγ9Vδ2+ T-cells, REST expanded Vγ9Vδ2+ T-cells + ZOL, ISO expanded Vγ9Vδ2+ T-cells, and ISO expanded Vγ9Vδ2+ T-cells + ZOL. BLI intensity on a scale from low (purple) to high (red). Data are represented as mean ± SEM; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 by Students two-tailed paired t test (B); Repeated measures two-way ANOVA or LMM with Bonferroni post hoc test (C–D); log-rank (Mantel–Cox) test (D).